KPTI·48576U205·US·equity·Healthcare - Biotechnology-13D/G
KPTI (KARYOPHARM THERAPEUTICS INC) is held by 41 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($10.7M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($10.1M), GOLDMAN SACHS GROUP INC ($5.3M). Net institutional sentiment: Bullish.
See how KPTI's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer